首页> 外文期刊>Post?py Higieny i Medycyny Do?wiadczalnej >Ferrytyna jako potencjalny Ferritin as a potential biomarker of efficacy of treatment of atrial fibrillation - preliminary reportskuteczno?ci leczenia migotania przedsionków - doniesienie wst?pne
【24h】

Ferrytyna jako potencjalny Ferritin as a potential biomarker of efficacy of treatment of atrial fibrillation - preliminary reportskuteczno?ci leczenia migotania przedsionków - doniesienie wst?pne

机译:铁蛋白作为治疗房颤的潜在生物标志物-关于房颤治疗有效性的初步报告-初步报告

获取原文
           

摘要

Background: Complex mechanisms of responsible for originating and maintaining of atrial fibrillation (AF) are involved in pathophysiology of this arrhythmia. Inflammation substantially contribute to arrhythmic remodelling of atrial tissue.The aim of the present study is to assess an applicability of ferritin and high sensitive C-reactive protein (hs-CRP) as biomarkers of atrial fibrillation and their usefulness in evaluation of efficacy of cryoablation. Materials and methods: The study population consisted of 40 patients who underwent first AF cryoablation procedure. The whole follow-up time was for 6 months. The efficacy of cryoablation was defined as lack of episodes of AF longer than 30 s reported either in patient’s medical documentation or present in standard or Holter ECG records. Concentrations of hs-CRP (latex method ) and ferritin (immunochemical method) were determined in standard way in hospital laboratory. Results: The recurrence of atrial fibrillation during follow-up was detected in 7 of 40 patients (efficacy 82.5%). Basal concentrations of hs-CRP and ferritin were significantly higher in patients who underwent ablation during AF. Ablation resulted in an increase of either hs-CRP or ferritin concentrations. After seven days, both hs-CRP and ferritin concentrations returned to basal level. The trend toward the higher concentration of hs-CRP was observed in AF recurrence subgroup in 30th and the 90th day after the procedure. Ferritin concentrations were significantly higher in recurrence subgroup after 30 and 90 days.
机译:背景:负责心律失常的复杂机制与心律失常的病理生理有关。炎症在很大程度上促进了心房组织的心律失常重塑。本研究的目的是评估铁蛋白和高敏C反应蛋白(hs-CRP)作为房颤的生物标志物的适用性及其在评估消融效果方面的实用性。材料和方法:研究人群包括40例接受首次AF冷冻消融手术的患者。整个随访时间为6个月。冷冻消融的疗效被定义为在患者的医疗文档中或标准或动态心电图记录中没有出现超过30秒的房颤发作。在医院实验室以标准方法测定hs-CRP(乳胶法)和铁蛋白(免疫化学法)的浓度。结果:40例患者中有7例在随访中发现房颤复发(有效率82.5%)。在房颤期间接受消融的患者中hs-CRP和铁蛋白的基础浓度显着较高。消融导致hs-CRP或铁蛋白浓度增加。 7天后,hs-CRP和铁蛋白浓度均恢复到基础水平。术后第30天和第90天,AF复发亚组观察到hs-CRP浓度升高的趋势。 30天和90天后,复发亚组的铁蛋白浓度显着升高。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号